Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18327
Country/Region: Zambia
Year: 2018
Main Partner: Catholic Relief Services
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $11,897,776 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $827,720
Care: TB/HIV (HVTB) $532,600
Care: Pediatric Care and Support (PDCS) $1,000,000
Health Systems Strengthening (OHSS) $68,499
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $620,000
Testing: HIV Testing and Counseling (HVCT) $1,233,384
Sexual Prevention: Other Sexual Prevention (HVOP) $290,529
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,482,537
Treatment: Adult Treatment (HTXS) $4,550,000
Treatment: Pediatric Treatment (PDTX) $1,292,507
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_SELF 2019 34,097
HTS_SELF 10-14, Female, Directly-Assisted 2019 339
HTS_SELF 10-14, Female, Unassisted 2019 672
HTS_SELF 10-14, Male, Directly-Assisted 2019 339
HTS_SELF 10-14, Male, Unassisted 2019 672
HTS_SELF 15-19, Female, Directly-Assisted 2019 1,011
HTS_SELF 15-19, Female, Unassisted 2019 1,011
HTS_SELF 15-19, Male, Directly-Assisted 2019 672
HTS_SELF 15-19, Male, Unassisted 2019 672
HTS_SELF 20-24, Female, Directly-Assisted 2019 1,347
HTS_SELF 20-24, Female, Unassisted 2019 1,347
HTS_SELF 20-24, Male, Directly-Assisted 2019 1,347
HTS_SELF 20-24, Male, Unassisted 2019 1,347
HTS_SELF 25-29, Female, Directly-Assisted 2019 1,347
HTS_SELF 25-29, Female, Unassisted 2019 1,347
HTS_SELF 25-29, Male, Directly-Assisted 2019 1,347
HTS_SELF 25-29, Male, Unassisted 2019 1,347
HTS_SELF 30-34, Female, Directly-Assisted 2019 1,347
HTS_SELF 30-34, Female, Unassisted 2019 1,347
HTS_SELF 30-34, Male, Directly-Assisted 2019 1,347
HTS_SELF 30-34, Male, Unassisted 2019 1,347
HTS_SELF 35-39, Female, Directly-Assisted 2019 1,347
HTS_SELF 35-39, Female, Unassisted 2019 1,346
HTS_SELF 35-39, Male, Directly-Assisted 2019 1,347
HTS_SELF 35-39, Male, Unassisted 2019 1,346
HTS_SELF 40-49, Female, Directly-Assisted 2019 1,347
HTS_SELF 40-49, Female, Unassisted 2019 1,346
HTS_SELF 40-49, Male, Directly-Assisted 2019 1,347
HTS_SELF 40-49, Male, Unassisted 2019 1,345
HTS_SELF 50+, Female, Directly-Assisted 2019 338
HTS_SELF 50+, Female, Unassisted 2019 336
HTS_SELF 50+, Male, Directly-Assisted 2019 338
HTS_SELF 50+, Male, Unassisted 2019 381
HTS_SELF Directly-Assisted 2019 16,888
HTS_SELF FSW, Directly-Assisted 2019 10,115
HTS_SELF FSW, Unassisted 2019 11,695
HTS_SELF MSM, Directly-Assisted 2019 5,058
HTS_SELF MSM, Unassisted 2019 6,213
HTS_SELF Unassisted 2019 17,209
HTS_SELF Unassisted - Other 2019 4,301
HTS_SELF Unassisted - Self 2019 8,607
HTS_SELF Unassisted - Sex Partner 2019 4,301
HTS_TST <5, Unknown Sex, Negative 2019 396
HTS_TST 1-9, Unknown Sex, Negative 2019 310
HTS_TST 1-9, Unknown Sex, Negative 2019 1
HTS_TST 10-14, Female, Negative 2019 49
HTS_TST 10-14, Female, Negative 2019 72
HTS_TST 10-14, Male, Negative 2019 23
HTS_TST 10-14, Male, Negative 2019 46
HTS_TST 15-19, Female, Negative 2019 458
HTS_TST 15-19, Female, Negative 2019 506
HTS_TST 15-19, Male, Negative 2019 127
HTS_TST 15-19, Male, Negative 2019 134
HTS_TST 20-24, Female, Negative 2019 407
HTS_TST 20-24, Female, Negative 2019 458
HTS_TST 20-24, Male, Negative 2019 244
HTS_TST 20-24, Male, Negative 2019 239
HTS_TST 25-29, Female, Negative 2019 87
HTS_TST 25-29, Female, Negative 2019 3,296
HTS_TST 25-29, Female, Negative 2019 184
HTS_TST 25-29, Female, Negative 2019 233
HTS_TST 25-29, Female, Negative 2019 492
HTS_TST 25-29, Female, Negative 2019 284
HTS_TST 25-29, Female, Negative 2019 110
HTS_TST 25-29, Female, Negative 2019 439
HTS_TST 25-29, Female, Negative 2019 3,459
HTS_TST 25-29, Female, Negative 2019 65
HTS_TST 25-29, Female, Negative 2019 7,660
HTS_TST 25-29, Female, Negative 2019 258
HTS_TST 25-29, Male, Negative 2019 93
HTS_TST 25-29, Male, Negative 2019 3,427
HTS_TST 25-29, Male, Negative 2019 184
HTS_TST 25-29, Male, Negative 2019 295
HTS_TST 25-29, Male, Negative 2019 243
HTS_TST 25-29, Male, Negative 2019 479
HTS_TST 25-29, Male, Negative 2019 299
HTS_TST 25-29, Male, Negative 2019 114
HTS_TST 25-29, Male, Negative 2019 440
HTS_TST 25-29, Male, Negative 2019 3,467
HTS_TST 25-29, Male, Negative 2019 69
HTS_TST 25-29, Male, Negative 2019 259
HTS_TST 30-34, Female, Negative 2019 87
HTS_TST 30-34, Female, Negative 2019 3,296
HTS_TST 30-34, Female, Negative 2019 184
HTS_TST 30-34, Female, Negative 2019 233
HTS_TST 30-34, Female, Negative 2019 494
HTS_TST 30-34, Female, Negative 2019 284
HTS_TST 30-34, Female, Negative 2019 110
HTS_TST 30-34, Female, Negative 2019 439
HTS_TST 30-34, Female, Negative 2019 3,459
HTS_TST 30-34, Female, Negative 2019 65
HTS_TST 30-34, Female, Negative 2019 5,745
HTS_TST 30-34, Female, Negative 2019 238
HTS_TST 30-34, Male, Negative 2019 246
HTS_TST 30-34, Male, Negative 2019 93
HTS_TST 30-34, Male, Negative 2019 3,427
HTS_TST 30-34, Male, Negative 2019 184
HTS_TST 30-34, Male, Negative 2019 295
HTS_TST 30-34, Male, Negative 2019 244
HTS_TST 30-34, Male, Negative 2019 469
HTS_TST 30-34, Male, Negative 2019 299
HTS_TST 30-34, Male, Negative 2019 114
HTS_TST 30-34, Male, Negative 2019 460
HTS_TST 30-34, Male, Negative 2019 3,467
HTS_TST 30-34, Male, Negative 2019 69
HTS_TST 35-39, Female, Negative 2019 248
HTS_TST 35-39, Female, Negative 2019 87
HTS_TST 35-39, Female, Negative 2019 3,358
HTS_TST 35-39, Female, Negative 2019 184
HTS_TST 35-39, Female, Negative 2019 233
HTS_TST 35-39, Female, Negative 2019 492
HTS_TST 35-39, Female, Negative 2019 284
HTS_TST 35-39, Female, Negative 2019 110
HTS_TST 35-39, Female, Negative 2019 459
HTS_TST 35-39, Female, Negative 2019 3,459
HTS_TST 35-39, Female, Negative 2019 65
HTS_TST 35-39, Female, Negative 2019 3,830
HTS_TST 35-39, Male, Negative 2019 246
HTS_TST 35-39, Male, Negative 2019 93
HTS_TST 35-39, Male, Negative 2019 3,448
HTS_TST 35-39, Male, Negative 2019 184
HTS_TST 35-39, Male, Negative 2019 295
HTS_TST 35-39, Male, Negative 2019 244
HTS_TST 35-39, Male, Negative 2019 469
HTS_TST 35-39, Male, Negative 2019 299
HTS_TST 35-39, Male, Negative 2019 114
HTS_TST 35-39, Male, Negative 2019 521
HTS_TST 35-39, Male, Negative 2019 3,467
HTS_TST 35-39, Male, Negative 2019 69
HTS_TST 40-49, Female, Negative 2019 238
HTS_TST 40-49, Female, Negative 2019 87
HTS_TST 40-49, Female, Negative 2019 3,296
HTS_TST 40-49, Female, Negative 2019 184
HTS_TST 40-49, Female, Negative 2019 233
HTS_TST 40-49, Female, Negative 2019 492
HTS_TST 40-49, Female, Negative 2019 284
HTS_TST 40-49, Female, Negative 2019 110
HTS_TST 40-49, Female, Negative 2019 459
HTS_TST 40-49, Female, Negative 2019 3,459
HTS_TST 40-49, Female, Negative 2019 65
HTS_TST 40-49, Female, Negative 2019 1,913
HTS_TST 40-49, Male, Negative 2019 246
HTS_TST 40-49, Male, Negative 2019 93
HTS_TST 40-49, Male, Negative 2019 3,548
HTS_TST 40-49, Male, Negative 2019 184
HTS_TST 40-49, Male, Negative 2019 295
HTS_TST 40-49, Male, Negative 2019 244
HTS_TST 40-49, Male, Negative 2019 479
HTS_TST 40-49, Male, Negative 2019 299
HTS_TST 40-49, Male, Negative 2019 117
HTS_TST 40-49, Male, Negative 2019 450
HTS_TST 40-49, Male, Negative 2019 3,467
HTS_TST 40-49, Male, Negative 2019 69
HTS_TST 50+, Female, Negative 2019 321
HTS_TST 50+, Female, Negative 2019 320
HTS_TST 50+, Male, Negative 2019 301
HTS_TST 50+, Male, Negative 2019 312
HTS_TST By Key Population: FSW, Negative 2019 537
HTS_TST By Key Population: MSM, Negative 2019 79
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2019 339
HTS_TST By Key Population: TG, Negative 2019 9
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 268,794
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 1,411
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 33
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 112
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 701
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 330
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 665
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 492
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 528
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 379
HTS_TST Service Delivery Point (Community) Mobile Testing: 1-9, Negative 2019 459
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2019 204
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2019 47
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 233
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 58
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 194
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 247
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 152
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 147
HTS_TST Service Delivery Point (Community) Other: 15-19, Female, Negative 2019 132
HTS_TST Service Delivery Point (Community) Other: 15-19, Male, Negative 2019 36
HTS_TST Service Delivery Point (Community) Other: 20-24, Female, Negative 2019 120
HTS_TST Service Delivery Point (Community) Other: 20-24, Male, Negative 2019 70
HTS_TST Service Delivery Point (Community) Other: 50+, Female, Negative 2019 91
HTS_TST Service Delivery Point (Community) Other: 50+, Male, Negative 2019 88
HTS_TST Service Delivery Point (Community) VCT Mod: 1-9, Negative 2019 283
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Female, Negative 2019 47
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Male, Negative 2019 24
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 400
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 122
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 367
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 184
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2019 274
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 245
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 195
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 7,982
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 11,029
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 580
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 1,840
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 297
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 163
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 855
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 369
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 887
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 517
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 737
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 490
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 3,727
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 600
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 331
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 592
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 152
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 518
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 317
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 405
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 379
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 22,836
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 5,002
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 2,713
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 7,527
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 1,912
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 6,947
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 3,643
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 4,502
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 4,192
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 7,768
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 99
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 47
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 93
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 99
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 119
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 247
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 9,335
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 1,506
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 841
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 6,548
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 1,820
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 6,068
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 3,530
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 4,449
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 4,222
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 236
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 1,415
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 1,415
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2019 471
HTS_TST_POS <5, Unknown Sex, Positive 2019 82
HTS_TST_POS 1-9, Unknown Sex, Positive 2019 5
HTS_TST_POS 10-14, Female, Positive 2019 12
HTS_TST_POS 10-14, Male, Positive 2019 4
HTS_TST_POS 15-19, Female, Positive 2019 9
HTS_TST_POS 15-19, Female, Positive 2019 30
HTS_TST_POS 15-19, Male, Positive 2019 7
HTS_TST_POS 20-24, Female, Positive 2019 9
HTS_TST_POS 20-24, Female, Positive 2019 33
HTS_TST_POS 20-24, Male, Positive 2019 43
HTS_TST_POS 25-29, Female, Positive 2019 45
HTS_TST_POS 25-29, Female, Positive 2019 246
HTS_TST_POS 25-29, Female, Positive 2019 11
HTS_TST_POS 25-29, Female, Positive 2019 2
HTS_TST_POS 25-29, Female, Positive 2019 168
HTS_TST_POS 25-29, Female, Positive 2019 32
HTS_TST_POS 25-29, Female, Positive 2019 16
HTS_TST_POS 25-29, Female, Positive 2019 194
HTS_TST_POS 25-29, Female, Positive 2019 280
HTS_TST_POS 25-29, Female, Positive 2019 6
HTS_TST_POS 25-29, Female, Positive 2019 404
HTS_TST_POS 25-29, Female, Positive 2019 30
HTS_TST_POS 25-29, Male, Positive 2019 52
HTS_TST_POS 25-29, Male, Positive 2019 352
HTS_TST_POS 25-29, Male, Positive 2019 15
HTS_TST_POS 25-29, Male, Positive 2019 3
HTS_TST_POS 25-29, Male, Positive 2019 2
HTS_TST_POS 25-29, Male, Positive 2019 229
HTS_TST_POS 25-29, Male, Positive 2019 36
HTS_TST_POS 25-29, Male, Positive 2019 25
HTS_TST_POS 25-29, Male, Positive 2019 214
HTS_TST_POS 25-29, Male, Positive 2019 517
HTS_TST_POS 25-29, Male, Positive 2019 4
HTS_TST_POS 25-29, Male, Positive 2019 39
HTS_TST_POS 30-34, Female, Positive 2019 45
HTS_TST_POS 30-34, Female, Positive 2019 246
HTS_TST_POS 30-34, Female, Positive 2019 11
HTS_TST_POS 30-34, Female, Positive 2019 2
HTS_TST_POS 30-34, Female, Positive 2019 168
HTS_TST_POS 30-34, Female, Positive 2019 32
HTS_TST_POS 30-34, Female, Positive 2019 16
HTS_TST_POS 30-34, Female, Positive 2019 194
HTS_TST_POS 30-34, Female, Positive 2019 280
HTS_TST_POS 30-34, Female, Positive 2019 6
HTS_TST_POS 30-34, Female, Positive 2019 305
HTS_TST_POS 30-34, Female, Positive 2019 30
HTS_TST_POS 30-34, Male, Positive 2019 39
HTS_TST_POS 30-34, Male, Positive 2019 52
HTS_TST_POS 30-34, Male, Positive 2019 352
HTS_TST_POS 30-34, Male, Positive 2019 15
HTS_TST_POS 30-34, Male, Positive 2019 3
HTS_TST_POS 30-34, Male, Positive 2019 2
HTS_TST_POS 30-34, Male, Positive 2019 229
HTS_TST_POS 30-34, Male, Positive 2019 36
HTS_TST_POS 30-34, Male, Positive 2019 25
HTS_TST_POS 30-34, Male, Positive 2019 212
HTS_TST_POS 30-34, Male, Positive 2019 517
HTS_TST_POS 30-34, Male, Positive 2019 4
HTS_TST_POS 35-39, Female, Positive 2019 30
HTS_TST_POS 35-39, Female, Positive 2019 45
HTS_TST_POS 35-39, Female, Positive 2019 246
HTS_TST_POS 35-39, Female, Positive 2019 11
HTS_TST_POS 35-39, Female, Positive 2019 2
HTS_TST_POS 35-39, Female, Positive 2019 168
HTS_TST_POS 35-39, Female, Positive 2019 32
HTS_TST_POS 35-39, Female, Positive 2019 16
HTS_TST_POS 35-39, Female, Positive 2019 189
HTS_TST_POS 35-39, Female, Positive 2019 280
HTS_TST_POS 35-39, Female, Positive 2019 6
HTS_TST_POS 35-39, Female, Positive 2019 200
HTS_TST_POS 35-39, Male, Positive 2019 39
HTS_TST_POS 35-39, Male, Positive 2019 52
HTS_TST_POS 35-39, Male, Positive 2019 352
HTS_TST_POS 35-39, Male, Positive 2019 15
HTS_TST_POS 35-39, Male, Positive 2019 3
HTS_TST_POS 35-39, Male, Positive 2019 2
HTS_TST_POS 35-39, Male, Positive 2019 229
HTS_TST_POS 35-39, Male, Positive 2019 36
HTS_TST_POS 35-39, Male, Positive 2019 25
HTS_TST_POS 35-39, Male, Positive 2019 212
HTS_TST_POS 35-39, Male, Positive 2019 517
HTS_TST_POS 35-39, Male, Positive 2019 4
HTS_TST_POS 40-49, Female, Positive 2019 30
HTS_TST_POS 40-49, Female, Positive 2019 45
HTS_TST_POS 40-49, Female, Positive 2019 246
HTS_TST_POS 40-49, Female, Positive 2019 11
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Female, Positive 2019 168
HTS_TST_POS 40-49, Female, Positive 2019 32
HTS_TST_POS 40-49, Female, Positive 2019 16
HTS_TST_POS 40-49, Female, Positive 2019 189
HTS_TST_POS 40-49, Female, Positive 2019 280
HTS_TST_POS 40-49, Female, Positive 2019 6
HTS_TST_POS 40-49, Female, Positive 2019 107
HTS_TST_POS 40-49, Male, Positive 2019 39
HTS_TST_POS 40-49, Male, Positive 2019 52
HTS_TST_POS 40-49, Male, Positive 2019 352
HTS_TST_POS 40-49, Male, Positive 2019 15
HTS_TST_POS 40-49, Male, Positive 2019 3
HTS_TST_POS 40-49, Male, Positive 2019 2
HTS_TST_POS 40-49, Male, Positive 2019 229
HTS_TST_POS 40-49, Male, Positive 2019 36
HTS_TST_POS 40-49, Male, Positive 2019 25
HTS_TST_POS 40-49, Male, Positive 2019 212
HTS_TST_POS 40-49, Male, Positive 2019 517
HTS_TST_POS 40-49, Male, Positive 2019 4
HTS_TST_POS 50+, Female, Positive 2019 42
HTS_TST_POS 50+, Male, Positive 2019 62
HTS_TST_POS 50+, Male, Positive 2019 6
HTS_TST_POS By Key Population: FSW, Positive 2019 47
HTS_TST_POS By Key Population: MSM, Positive 2019 5
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2019 43
HTS_TST_POS By Key Population: TG, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 87
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 7
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 173
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 138
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 197
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 178
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2019 306
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 426
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 1-9, Positive 2019 6
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2019 5
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 21
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 25
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 26
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 1-9, Positive 2019 6
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive 2019 11
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive 2019 24
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive 2019 11
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Female, Positive 2019 15
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Male, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 411
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 575
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 32
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 116
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 87
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 69
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 112
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 150
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 234
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 379
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 70
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 30
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 49
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 553
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 41
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 132
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 77
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 212
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 245
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 400
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 643
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 157
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 21
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 35
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 36
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 63
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 183
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 166
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 153
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 52
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 335
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 148
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 293
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 454
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2019 5
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 1,109
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 1,109
PMTCT_ART Already on ART at beginning of current pregnancy 2019 3,113
PMTCT_ART New on ART 2019 2,919
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 6,032
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 44,654
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 4,829
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 1,203
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 6,032
PMTCT_EID Sum of Infant Age disaggregates 2019 6,032
PMTCT_STAT 25-29, Female 2019 12,338
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 846
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 10,919
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 573
PMTCT_STAT 30-34, Female 2019 9,656
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 846
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 8,404
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 406
PMTCT_STAT 35-39, Female 2019 7,059
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 681
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 5,837
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 541
PMTCT_STAT 40-49, Female 2019 6,042
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 136
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 5,141
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 765
PMTCT_STAT By Age (Numerator): 15-19 2019 68
PMTCT_STAT By Age (Numerator): 20-24 2019 9,491
PMTCT_STAT By Number of known positives: 15-19 2019 8
PMTCT_STAT By Number of known positives: 20-24 2019 596
PMTCT_STAT By Number of new negative: 15-19 2019 1
PMTCT_STAT By Number of new negative: 20-24 2019 8,320
PMTCT_STAT By Number of new positives: 15-19 2019 59
PMTCT_STAT By Number of new positives: 20-24 2019 575
PMTCT_STAT Number of new ANC and L&D clients 2019 47,165
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 44,654
PMTCT_STAT_den 25-29, Female 2019 9,656
PMTCT_STAT_den 30-34, Female 2019 7,059
PMTCT_STAT_den 35-39, Female 2019 7,059
PMTCT_STAT_den By Age (Denominator): <15-19 2019 9,491
PMTCT_STAT_den By Age (Denominator): 10-14 2019 68
PMTCT_STAT_den By Age (Denominator): 20-24 2019 13,819
PMTCT_STAT_den By Age (Denominator): 50+ 2019 13
PP_PREV 25-29, Female 2019 720
PP_PREV 25-29, Male 2019 360
PP_PREV 30-34, Female 2019 360
PP_PREV 30-34, Male 2019 360
PP_PREV 35-39, Female 2019 360
PP_PREV 35-39, Male 2019 360
PP_PREV 40-49, Female 2019 360
PP_PREV 40-49, Male 2019 360
PP_PREV Age/sex: 10-14 Female 2019 360
PP_PREV Age/sex: 10-14 Male 2019 340
PP_PREV Age/sex: 15-19 Female 2019 360
PP_PREV Age/sex: 15-19 Male 2019 360
PP_PREV Age/sex: 20-24 Female 2019 1,720
PP_PREV Age/sex: 20-24 Male 2019 738
PP_PREV Age/sex: 50+ Female 2019 40
PP_PREV Age/sex: 50+ Male 2019 37
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 7,195
PP_PREV Sum of Age/Sex disaggregates 2019 3,955
PrEP_NEW 25-29, Female 2019 76
PrEP_NEW 25-29, Male 2019 137
PrEP_NEW 30-34, Female 2019 114
PrEP_NEW 30-34, Male 2019 23
PrEP_NEW 35-39, Female 2019 23
PrEP_NEW 35-39, Male 2019 6
PrEP_NEW 40-49, Female 2019 5
PrEP_NEW Female 20-24 2019 76
PrEP_NEW FSW 2019 265
PrEP_NEW MSM 2019 57
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 460
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 90
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 1,099
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 70
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 753
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 2,028
TB_PREV By Age/Sex (Numerator): <15, Female 2019 636
TB_PREV By Age/Sex (Numerator): <15, Male 2019 266
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 7,742
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 8,110
TB_PREV IPT, Life-long ART, New, Positive 2019 16,754
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 16,754
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 27,760
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 829
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 782
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 15,679
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 10,470
TB_PREV_den IPT, Life-long ART, New, Positive 2019 27,760
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 78
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,282
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 84
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 2,275
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 3,719
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 3,719
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 78
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,282
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 84
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 2,275
TX_CURR 25-29, Female, Positive 2019 9,209
TX_CURR 25-29, Male, Positive 2019 4,376
TX_CURR 30-34, Female, Positive 2019 11,296
TX_CURR 30-34, Male, Positive 2019 6,321
TX_CURR 35-39, Female, Positive 2019 11,367
TX_CURR 35-39, Male, Positive 2019 8,492
TX_CURR 40-49, Female, Positive 2019 17,510
TX_CURR 40-49, Male, Positive 2019 18,356
TX_CURR Age/Sex: <1 2019 1,578
TX_CURR Age/Sex: <1-9 2019 3,490
TX_CURR Age/Sex: 10-14 Female 2019 1,928
TX_CURR Age/Sex: 10-14 Male 2019 1,312
TX_CURR Age/Sex: 15-19 Female 2019 2,930
TX_CURR Age/Sex: 15-19 Male 2019 2,289
TX_CURR Age/Sex: 20-24 Female 2019 6,507
TX_CURR Age/Sex: 20-24 Male 2019 2,359
TX_CURR Age/Sex: 50+ Female 2019 9,334
TX_CURR Age/Sex: 50+ Male 2019 7,797
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 126,460
TX_CURR Sum of age/sex disaggregates 2019 5,219
TX_NEW 25-29, Female, Positive 2019 1,240
TX_NEW 25-29, Male, Positive 2019 677
TX_NEW 30-34, Female, Positive 2019 1,371
TX_NEW 30-34, Male, Positive 2019 948
TX_NEW 35-39, Female, Positive 2019 1,294
TX_NEW 35-39, Male, Positive 2019 1,064
TX_NEW 40-49, Female, Positive 2019 1,751
TX_NEW 40-49, Male, Positive 2019 2,273
TX_NEW Breastfeeding status 2019 4,020
TX_NEW By Age/Sex: <1 2019 34
TX_NEW By Age/Sex: 1-9 2019 1,176
TX_NEW By Age/Sex: 10-14 Female 2019 136
TX_NEW By Age/Sex: 10-14 Male 2019 175
TX_NEW By Age/Sex: 15-19 Female 2019 620
TX_NEW By Age/Sex: 15-19 Male 2019 515
TX_NEW By Age/Sex: 20-24 Female 2019 550
TX_NEW By Age/Sex: 20-24 Male 2019 469
TX_NEW By Age/Sex: 50+ Female 2019 1,997
TX_NEW By Age/Sex: 50+ Male 2019 3,151
TX_NEW FSW 2019 953
TX_NEW MSM 2019 1,028
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 19,451
TX_NEW Pregnancy status 2019 2,871
TX_NEW Sum of Age/Sex disaggregates 2019 7,613
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 126,242
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 4,315
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 3,849
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 67,984
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 50,185
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 1,481
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 1,127
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 13,942
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 12,837
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 29,387
TX_RET Numerator by Status: Breastfeeding 2019 1,395
TX_RET Numerator by Status: Pregnant 2019 5,294
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 32,003
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,630
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,236
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 15,279
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 13,858
TX_RET_den Denominator by Status: Breastfeeding 2019 1,528
TX_RET_den Denominator by Status: Pregnant 2019 5,804
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 135,088
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 5,401
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 4,052
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 72,947
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 52,688
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 135,088
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 135,088
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 135,088
VMMC_CIRC 30-34, Male 2019 338
VMMC_CIRC 35-39, Male 2019 339
VMMC_CIRC 40-49, Male 2019 293
VMMC_CIRC By Age: 0-60 days 2019 7
VMMC_CIRC By Age: 10-14 2019 337
VMMC_CIRC By Age: 15-19 2019 2,232
VMMC_CIRC By Age: 2 months - 9 years 2019 18
VMMC_CIRC By Age: 20-24 2019 1,580
VMMC_CIRC By Age: 25-29 2019 763
VMMC_CIRC By Age: 50+ 2019 158
VMMC_CIRC By circumcision technique: Surgical VMMC 2019 6,065
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 6,065
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2019 5,070
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2019 4,307
Cross Cutting Budget Categories and Known Amounts Total: $1,718,860
Key Populations: Sex Workers $50,000
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Key Populations: MSM and TG $30,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Condoms: Policy, Tools, and Services $25,000
Human Resources for Health $1,613,860